MedPath

University of California, Los Angeles

University of California, Los Angeles logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1919-05-23
Employees
10K
Market Cap
-
Website
http://www.ucla.edu

Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy

Phase 4
Completed
Conditions
Pain, Postoperative
Analgesics, Opioid
Analgesics, Non-Narcotic
Physiological Effects of Drugs
Peripheral Nervous System Agents
Patient Satisfaction
Return to Work
Activity, Sexual
Interventions
Drug: Abdominal wall block with liposomal bupivicaine
First Posted Date
2017-09-26
Last Posted Date
2022-01-10
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
146
Registration Number
NCT03294109
Locations
🇺🇸

Connie Frank Kidney Transplant Center, Los Angeles, California, United States

Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners

Not Applicable
Completed
Conditions
HIV Infections
Interventions
Behavioral: Optimized PITC
Diagnostic Test: Facility HIVST
Diagnostic Test: Index HIVST
First Posted Date
2017-09-05
Last Posted Date
2020-12-02
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
6369
Registration Number
NCT03271307
Locations
🇲🇼

Partners in Hope, Lilongwe, Malawi

Envarsus XR® in Adolescent Renal Transplant Recipients

Phase 4
Active, not recruiting
Conditions
Kidney Transplantation
Renal Transplantation
Grafting, Kidney
Interventions
First Posted Date
2017-08-30
Last Posted Date
2023-02-09
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
28
Registration Number
NCT03266393
Locations
🇺🇸

UCLA Transplantation Services, Los Angeles, California, United States

Pre-Operative Testing for Cataract Surgery Among Adults in LA County

Not Applicable
Completed
Conditions
Cataract
Interventions
Behavioral: No Pre-Op Testing for Cataract Surgeries
First Posted Date
2017-08-18
Last Posted Date
2017-08-18
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
1798
Registration Number
NCT03253874

Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response

Not Applicable
Completed
Conditions
Children With Autism
Interventions
Behavioral: PARENT focused intervention
Behavioral: CHILD focused intervention
First Posted Date
2017-08-17
Last Posted Date
2024-12-05
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
81
Registration Number
NCT03253081
Locations
🇺🇸

UCLA Semel Institute, Los Angeles, California, United States

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

Phase 1
Completed
Conditions
HIV/AIDS
Antiviral Drug Adverse Reaction
Antiviral Toxicity
Mitochondrial Alteration
Interventions
Drug: Switch to E/C/FTC/TAF daily
First Posted Date
2017-08-16
Last Posted Date
2022-05-10
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
26
Registration Number
NCT03251144
Locations
🇺🇸

UCLA CARE Center, Los Angeles, California, United States

Target Engagement and Response to Oxytocin

Phase 4
Active, not recruiting
Conditions
Schizophrenia
Interventions
Drug: Oxytocin nasal spray
Behavioral: Health Management
Drug: Placebo nasal spray
Behavioral: Social Cognition Skills Training
First Posted Date
2017-08-10
Last Posted Date
2024-03-15
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
120
Registration Number
NCT03245437
Locations
🇺🇸

UCLA, Los Angeles, California, United States

FODMAP Reintroduction in Irritable Bowel Syndrome

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome With Mixed Bowel Habits
Irritable Bowel Syndrome With Diarrhea
Interventions
Other: Dietary Intervention
First Posted Date
2017-08-10
Last Posted Date
2023-07-11
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
30
Registration Number
NCT03245645
Locations
🇺🇸

UCLA, Los Angeles, California, United States

Transcutaneous Electrical Acupoint Stimulation (TEAS) for Chronic Constipation

Not Applicable
Recruiting
Conditions
Constipation - Functional
Interventions
Device: Verum TEAS
Device: Sham TEAS
First Posted Date
2017-08-09
Last Posted Date
2023-10-03
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
100
Registration Number
NCT03243955
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD

Phase 2
Active, not recruiting
Conditions
ASD
Interventions
Drug: L-DOPA versus Placebo
Behavioral: Social Skills Training
First Posted Date
2017-08-09
Last Posted Date
2023-06-28
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
56
Registration Number
NCT03243552
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath